Ironwood Pharmaceuticals: One Trial Stands Between Bargain And Bust (NASDAQ:IRWD)
· seekingalpha.com
Ironwood Pharmaceuticals trades at a 40% discount to its risk-adjusted SOTP valuation, anchored by LINZESS and apraglutide. Read more on IRWD stock here.
Ironwood Pharmaceuticals, Inc. ( IRWD ) is currently priced at a 40% discount to the risk-adjusted sum-of-the-parts value. In this article, I break down the val...